Neurology · 2017 · 30 citations · 23 references
Life SciencesNeurologyNeuroscienceClinical NeuroscienceNeurodegenerationNeuropathologyBiomarkers Of NeurodegenerationMultiple System AtrophyNeurodegenerative Disease ImagingNeurodegenerative DiseasesNeurodegenerative DisordersAdvocacy OrganizationsKnowledge GapsNeurodegenerative Disease BiomarkersNeurological Disease BiomarkersPreclinical BiomarkersPreclinical Disease ModelingResearch Priority SettingTherapeutic Target Identification
Multiple system atrophy (MSA) is a rare neurodegenerative disorder with substantial knowledge gaps despite recent gains in basic and clinical research. In order to make further advances, concerted international collaboration is vital. In 2014, an international meeting involving leaders in the field and MSA advocacy groups was convened in Las Vegas, Nevada, to identify critical research areas where consensus and progress was needed to improve understanding, diagnosis, and treatment of the disease. Eight topic areas were defined: pathogenesis, preclinical modeling, target identification, endophenotyping, clinical measures, imaging biomarkers, nonimaging biomarkers, treatments/trial designs, and patient advocacy. For each topic area, an expert served as a working group chair and each working group developed priority-ranked research recommendations with associated timelines and pathways to reach the intended goals. In this report, each groups' recommendations are provided.
23
Christopher G. Goetz, Barbara C. Tilley, Stephanie R. Shaftman et al. · Movement Disorders · 2008 · 7.5K citations · Full text
Second consensus statement on the diagnosis of multiple system atrophy
S. Gilman, Gregor K. Wenning, Phillip A. Low et al. · Neurology · 2008 · 3.2K citations · Full text
Christopher G. Goetz, Stanley Fahn, Pablo Martínez‐Martín et al. · Movement Disorders · 2006 · 1.4K citations · Full text
Clinical features and natural history of multiple system atrophy
Gregor K. Wenning, Y. Ben Shlomo, Marina Magalhães et al. · Brain · 1994 · 783 citations